Tobramycin

220px
Tobramycin
Systematic (IUPAC) name
4-amino-2-[4,6-diamino-3- [3-amino-6-(aminomethyl) -5-hydroxy-tetrahydropyran-2-yl]oxy- 2-hydroxy-cyclohexoxy]-6-(hydroxymethyl) tetrahydropyran-3,5-diol
Identifiers
CAS number	32986-56-4
ATC code	J01GB01 S01AA12
PubChem	5496
DrugBank	APRD00582
Chemical data
Formula	C18H37N5O9
Mol. mass	467.515 g/mol
Pharmacokinetic data
Bioavailability	?
Protein binding	< 30%
Metabolism	?
Half life	Neonates < 1200 g: 11 hrs; > 1200 g 2-9 hrs Adults: 2-3 hours; longer with impaired renal function
Excretion	?
Therapeutic considerations
Pregnancy cat.	D (Injection, Inhalation); B (Ophthalmic) (US)
Legal status
Routes	IV, IM, inhalation, ophthalmic

WikiDoc Resources for Tobramycin
Articles
Most recent articles on Tobramycin Most cited articles on Tobramycin Review articles on Tobramycin Articles on Tobramycin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tobramycin Images of Tobramycin Photos of Tobramycin Podcasts & MP3s on Tobramycin Videos on Tobramycin
Evidence Based Medicine
Cochrane Collaboration on Tobramycin Bandolier on Tobramycin TRIP on Tobramycin
Clinical Trials
Ongoing Trials on Tobramycin at Clinical Trials.gov Trial results on Tobramycin Clinical Trials on Tobramycin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tobramycin NICE Guidance on Tobramycin NHS PRODIGY Guidance FDA on Tobramycin CDC on Tobramycin
Books
Books on Tobramycin
News
Tobramycin in the news Be alerted to news on Tobramycin News trends on Tobramycin
Commentary
Blogs on Tobramycin
Definitions
Definitions of Tobramycin
Patient Resources / Community
Patient resources on Tobramycin Discussion groups on Tobramycin Patient Handouts on Tobramycin Directions to Hospitals Treating Tobramycin Risk calculators and risk factors for Tobramycin
Healthcare Provider Resources
Symptoms of Tobramycin Causes & Risk Factors for Tobramycin Diagnostic studies for Tobramycin Treatment of Tobramycin
Continuing Medical Education (CME)
CME Programs on Tobramycin
International
Tobramycin en Espanol Tobramycin en Francais
Business
Tobramycin in the Marketplace Patents on Tobramycin
Experimental / Informatics
List of terms related to Tobramycin

Tobramycin sulfate is an aminoglycoside antibiotic used to treat various types of bacterial infections, particularly Gram-negative infections.

Mechanism of action

Tobramycin works by binding to a site on the bacterial 30S and 50S ribosome, preventing formation of the 70S complex. As a result, mRNA cannot be translated into protein and cell death ensues.

Administration

Like all aminoglycosides, tobramycin does not pass the gastro-intestinal tract, so for systemic use it can only be given intravenously or intramuscularly. This formulation for injection is branded Nebcin®. Patients with cystic fibrosis will often take an inhalational form (Tobi®) for suppression of Pseudomonas aeruginosa infections. Tobramycin is also combined with dexamethasone as an ophthalmic solution (TobraDex®).

Bausch & Lomb Pharmaceuticals, Inc. makes a sterile Tobramycin Ophthalmic Solution (eye-drops) with a tobramycin concentration of 0.3%, which is available by prescription only in the United States and Canada. (In some countries, such as Italy, it is available over the counter.) It is mixed with 0.01% benzalkonium chloride as a preservative. These concentrations result in 3 mg per ml and 0.1 mg per ml, respectively.

Side effects

Like other aminoglycosides, tobramycin can cause deafness or a loss of equilibrioception (vertigo) in genetically susceptible individuals. These individuals have a normally harmless mutation in their DNA, that allows the tobramycin to affect their cells. The cells of the ear are particularly sensitive to this.

Tobramycin can also be highly toxic to the kidneys, particularly if multiple doses accumulate over a course of treatment.

For these reasons, when tobramycin is given parenterally, it is usually dosed by body weight. Various formulae exist for calculating tobramycin dosage. Also serum levels of tobramycin are monitored during treatment.

th:โทบรามัยซิน